Controlling and monitoring polymyositis under steroid therapy

Medical Hypotheses

Volumn 59, Issue 6, 2002, Pages 674-681

  Golding, Elke M ^a   Golding, R M ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TOWNSVILLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMBROTOSE; CREATINE KINASE; MUSCLE ANTIBODY; NATURAL PRODUCT; PHYTALOE; PREDNISOLONE; STEROID; UNCLASSIFIED DRUG;

CALCULATION; CREATINE KINASE BLOOD LEVEL; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; HUMAN; MODEL; MONITORING; MUSCLE INJURY; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; STEROID THERAPY; ARTICLE; BLOOD; METHODOLOGY; PATHOPHYSIOLOGY; REFERENCE VALUE;

CREATINE KINASE; DIETARY SUPPLEMENTS; HUMANS; MONITORING, PHYSIOLOGIC; POLYMYOSITIS; PREDNISOLONE; REFERENCE VALUES; STEROIDS;

EID: 0036903613     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00295-5     Document Type: Article

References (3)

1. Golding E. M., Golding R. M. An insight into cortisol and polymyositis control with steroid therapy. Med Hypotheses 2001; 57: 76-86.
2. Lundberg I., Chung Y. Treatment and investigation of idiopathic inflammatory myopathies. Rheumatology 2000; 39: 7-17.
3. Villalba L., Adams E. M. Update on therapy for refractory dermatomyositis and polymyositis. Curr Opin Rheumatol 1996; 8: 544-551.